scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029591377 |
P356 | DOI | 10.1186/S12943-015-0323-3 |
P932 | PMC publication ID | 4342823 |
P698 | PubMed publication ID | 25743273 |
P5875 | ResearchGate publication ID | 273952273 |
P50 | author | Wei Kang | Q56954147 |
Qiaoyi Liang | Q63437411 | ||
Ka Fai To | Q99551275 | ||
Alfred S. Cheng | Q44364620 | ||
P2093 | author name string | Li Zhang | |
Jun Yu | |||
Yi Pan | |||
Yujuan Dong | |||
Joanna H M Tong | |||
Raymond W M Lung | |||
Weiqin Yang | |||
Jesse C S Pang | |||
Junhong Zhao | |||
P2860 | cites work | Dysregulation of miR-15a and miR-214 in human pancreatic cancer | Q21198870 |
miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer | Q24632636 | ||
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia | Q24633394 | ||
MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E | Q28117082 | ||
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives | Q28247489 | ||
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia | Q28269786 | ||
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
Protein profiling of Helicobacter pylori-associated gastric cancer. | Q54373611 | ||
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 | ||
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma | Q28383997 | ||
MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors | Q28731854 | ||
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues | Q33403617 | ||
Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR | Q33589557 | ||
miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner | Q33901567 | ||
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. | Q34103666 | ||
Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer | Q34217592 | ||
miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro | Q34225986 | ||
let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. | Q34333720 | ||
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level | Q35632171 | ||
Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells | Q35887790 | ||
Histology-specific microRNA alterations in melanoma | Q36828567 | ||
Macro-role of microRNA in gastric cancer | Q38020729 | ||
Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival | Q38331873 | ||
Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. | Q39439183 | ||
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer | Q39550421 | ||
Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. | Q39586964 | ||
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. | Q44718219 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P921 | main subject | microRNA | Q310899 |
adenocarcinoma | Q356033 | ||
P304 | page(s) | 52 | |
P577 | publication date | 2015-02-22 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma | |
P478 | volume | 14 |
Q47678258 | A non-coding function of TYRP1 mRNA promotes melanoma growth. |
Q52562248 | A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy. |
Q89868771 | A transcriptional co-expression network-based approach to identify prognostic biomarkers in gastric carcinoma |
Q92095483 | AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis |
Q58599825 | Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 axis |
Q58790042 | Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma |
Q49272569 | Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression |
Q92738342 | Downregulation of miR‑16 protects H9c2(2‑1) cells against hypoxia/reoxygenation damage by targeting CIAPIN1 and regulating the NF‑κB pathway |
Q26780293 | Dysregulation of non-coding RNAs in gastric cancer |
Q26774473 | Emerging role of Hippo pathway in gastric and other gastrointestinal cancers |
Q26739018 | Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis |
Q64951868 | FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. |
Q37694670 | Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer |
Q92921699 | High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network |
Q40492737 | High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer |
Q37747546 | IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. |
Q47104709 | Identification of the key miRNAs associated with survival time in stomach adenocarcinoma |
Q57072133 | Inhibition of microRNA‑939 suppresses the development of human non‑small cell lung cancer via the upregulation of tissue inhibitor of metalloproteinases 2 |
Q90751756 | Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3 |
Q64103283 | Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis |
Q50417171 | MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. |
Q38698481 | MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer |
Q57167857 | MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt/β-catenin signaling pathway |
Q92637370 | MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis |
Q41025694 | MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study. |
Q38755853 | MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells |
Q51593946 | MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene. |
Q36546019 | MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma |
Q36429631 | MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAP |
Q37269100 | MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression. |
Q38742168 | MicroRNA-16-1 Inhibits Tumor Cell Proliferation and Induces Apoptosis in A549 Non-Small Cell Lung Carcinoma Cells |
Q38951353 | MicroRNA-181b suppresses TAG via target IRS2 and regulating multiple genes in the Hippo pathway |
Q99567216 | MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells |
Q90699235 | Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16 |
Q38741017 | Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways |
Q47221572 | SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. |
Q47126606 | TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. |
Q36992190 | Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). |
Q90162090 | The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview |
Q37686691 | The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p |
Q90532771 | The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma |
Q57929186 | Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas |
Q64095617 | Upregulated gga-miR-16-5p Inhibits the Proliferation Cycle and Promotes the Apoptosis of -Infected DF-1 Cells by Repressing PIK3R1-Mediated the PI3K/Akt/NF-κB Pathway to Exert Anti-Inflammatory Effect |
Q37000636 | Urinary miR-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion-induced injury |
Q40058632 | miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas |
Q37604616 | miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis |
Q36772022 | miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways |
Q48171440 | miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis |
Q41428675 | miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1. |
Search more.